20 completed, 3 not yet recruiting, 3 unknown, 1 recruiting. 28 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 28 | Completed 20, Not yet recruiting 3, Unknown 3, Recruiting 1, Terminated 1 |
Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis, Tinea Cruris | Phase 4 | Not yet recruiting | University of Faisalabad | 182 | 2026-12-01 | 2026-11-12 |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
| Oral Fluconazole vs Oral Terbinafine for Tinea Capitis in Children Aged 2-10 Years Fluconazole., Terbinafine., Ketoconazole 2% shampoo - Tinea Capitis | Phase 4 | Completed | Dr. Amara Safdar | 64 | 2025-12-01 | 2026-11-10 |
| Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis | Phase 4 | Recruiting | Urooj Fatima | 126 | 2025-11-01 | 2026-01-15 |
| Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis Topical Sertaconazole 2%, Clotrimazole 1% - Tinea Pedis | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 100 | 2025-03-01 | 2025-03-11 |
| Diode Laser and Photodynamic Therapy Vs. Ciclopirox. Diode laser combined with photodynamic-red laser therapy by RapidoPodia Laser Diodo®, Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer - Onychomycosis | Phase 4 | Unknown | Universidad Complutense de Madrid | 26 | 2023-09-01 | 2023-05-10 |
| Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis amphotericin B in 30% DMSO, 30% DMSO - Fungal Infection, Onychomycosis | Phase 4 | Completed | Mahidol University | 19 | 2019-01-15 | 2021-09-28 |
| Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis Jublia® - Mild to Moderate Onychomycosis Due to Dermatophyte | Phase 4 | Completed | Dong-A ST Co., Ltd. | 97 | 2017-11-10 | 2021-04-27 |
| Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis Efinaconazole - Onychomycosis | Phase 4 | Completed | Bausch Health Americas, Inc. | 62 | 2016-08-04 | 2021-11-01 |
| Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis 1,064nm Long-pulsed Nd:YAG, Amorolfine - Non-dermatophyte Onychomycosis | Phase 4 | Completed | Mahidol University | 60 | 2016-08-01 | 2021-09-28 |
| Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis Luliconazole Cream 1%, Vehicle Cream - Tinea Corporis | Phase 4 | Completed | Bausch Health Americas, Inc. | 75 | 2016-02-08 | 2019-11-27 |
| Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% Loceryl Nail Lacquer, Urea Ointment, Bifonazole Cream - Foot Dermatoses | Phase 4 | Completed | Galderma R&D | 22 | 2016-01-01 | 2021-02-17 |
| Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris Luliconazole Cream 1% - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Bausch Health Americas, Inc. | 30 | 2015-12-02 | 2019-11-27 |
| An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents Tavaborole 5% Topical Solution - Onychomycosis, Tinea Unguium | Phase 4 | Completed | Pfizer | 55 | 2015-10-22 | 2018-04-17 |
| Study Evaluating the Effect of Jublia on Dermatophytomas Jublia (Efinaconazole 10% Topical Solution) - Onychomycosis, Dermatophytosis | Phase 4 | Completed | University of Alabama at Birmingham | 19 | 2015-09-01 | 2019-12-10 |
| Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer Loceryl NL, Ciclopirox NL - Foot Dermatoses | Phase 4 | Completed | Galderma R&D | 20 | 2015-09-01 | 2021-03-22 |
| A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment Nailprotex - Onychomycosis, Chronic Paronychia | Phase 4 | Completed | Mahidol University | 19 | 2015-07-01 | 2016-06-17 |
| Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris Omeprazole 40 mg, Luliconazole Cream 1% - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Bausch & Lomb Incorporated | 20 | 2015-02-03 | 2019-11-27 |
| Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis CURE-EX device - Onychomycosis | Phase 4 | Unknown | MB Mazor Ltd. | 50 | 2014-10-01 | 2015-05-06 |
| Pediatric Subjects With Tinea Corporis Naftin Cream, Placebo Cream - Tinea Corporis | Phase 4 | Completed | Merz North America, Inc. | 230 | 2014-08-01 | 2016-10-28 |
Showing 20 of 28. Sign in to see all of them.
Onychomycosis (16) · Tinea Cruris (4) · Tinea Pedis (4) · Foot Dermatoses (3) · Mycoses (3) · Dermatomycoses (2) · Candidiasis (1) · Cellulitis (1) · Infections (1) · Nail Diseases (1) · Tinea Capitis (1)
Bacterial Infections and Mycoses (28) · Skin Diseases (28) · Skin Diseases, Infectious (28) · Skin and Connective Tissue Diseases (28) · Infections (27) · Dermatomycoses (26) · Mycoses (25) · Nail Diseases (15) · Foot Diseases (7) · Pathological Conditions, Signs and Symptoms (5) · Dermatitis (4) · Foot Dermatoses (4) · Intertrigo (4) · Pruritus (4)
Itraconazole (4) · Ciclopirox (3) · amorolfine (3) · efinaconazole (3) · Fluconazole (2) · Solutions (2) · Terbinafine (2) · Amphotericin B (1) · Antifungal Agents (1) · Dimethyl Sulfoxide (1) · Isotretinoin (1) · Keratolytic Agents (1) · Ketoconazole (1) · Lasers (1) · Omeprazole (1)
Bausch Health Americas, Inc. (3) · Galderma R&D (3) · Mahidol University (3) · Merz North America, Inc. (3) · Bausch & Lomb Incorporated (1) · Dong-A ST Co., Ltd. (1) · Dr. Amara Safdar (1) · Ferrer Internacional S.A. (1) · Helsinki University Central Hospital (1) · Janssen Korea, Ltd., Korea (1) · Jinnah Postgraduate Medical Centre (1) · MB Mazor Ltd. (1) · Pak Emirates Military Hospital (1) · Pfizer (1) · Pierre Fabre Dermo Cosmetique (1)
United States (8) · Dominican Republic (6) · Honduras (5) · Pakistan (4) · Thailand (3) · Iceland (2) · Finland (1) · France (1) · Germany (1) · Israel (1) · Panama (1) · Puerto Rico (1) · South Korea (1)
Anya Loncaric (3) · Alan Fleischer, MD (2) · Alan B. Fleischer, MD (1) · Avner Shemer, MD (1) · Binu Alexander, MD (1) · Boni E Elewski, MD (1) · Charussri Leeyaphan, MD (1) · Janne J. Jokinen, MD, PhD (1) · Jose C Moreno, Prof, PhD (1)
PMID 10233295, PMID 10642676, PMID 14723731, PMID 20347657, PMID 21820203, PMID 22236569, PMID 22976905, PMID 23278851, PMID 23416171, PMID 24079583, PMID 25013957, PMID 25639524, PMID 26471716, PMID 27799043, PMID 27815659, PMID 30811142, PMID 36103158, PMID 41024682
2008 (1), 2015 (1)